Antigen processing for MHC class I restricted presentation of exogenous influenza A virus nucleoprotein by B-lymphoblastoid cells

Clinical and Experimental Immunology

Volumn 125, Issue 3, 2001, Pages 423-431

  Voeten, J T M ^a   Rimmelzwaan, G F ^a   Nieuwkoop, N J ^a   Fouchier, R A M ^a   Osterhaus, A D M E ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Antigen processing; B lymphoblastoid cells; HLA B27; Influenza; Nucleoprotein

Indexed keywords

BREFELDIN A; CD4 ANTIGEN; CD8 ANTIGEN; CHLOROQUINE; HLA B27 ANTIGEN; LACTACYSTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NUCLEOPROTEIN; PROTEIN;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOBLAST; CELL LINE; CONTROLLED STUDY; CYTOPLASM; ENDOSOME; INFLUENZA VIRUS A; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS RECOMBINANT;

ACETYLCYSTEINE; ANTIGEN PRESENTATION; B-LYMPHOCYTES; BREFELDIN A; CHLOROQUINE; ENDOSOMES; ENZYME INHIBITORS; HEMATOPOIETIC STEM CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INFLUENZA A VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; NUCLEOPROTEINS; PEPTIDE FRAGMENTS; RNA-BINDING PROTEINS; VIRAL CORE PROTEINS;

EID: 0035717978     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2001.01613.x     Document Type: Article

References (49)

1. A molecular model of MHC class-I-restricted antigen processing
2. Cell biology of antigen presentation
3. Generation, translocation, and presentation of MHC class I-restricted peptides
4. + T lymphocytes
5. Antigen processing and presentation by the class I major histocompatibility complex
6. + cytotoxic T lymphocytes
7. Alternative pathways for processing exogenous and endogenous antigens that can generate peptide for MHC class I-restricted presentation
8. + T cell responses to infectious agents, tumors, transplants and vaccines
9. Accessory to murder
10. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen
11. Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules
12. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules
13. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigens by a subset of cells engaged in phagocytosis
14. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages
15. Presentation of exogenous proteins on major histocompatibility complex class I molecules by dendritic cells: Pathway of presentation and regulation by cytokines
16. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules
17. TAP1-independent loading of class I molecules by exogenous viral proteins
18. Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation
19. Roles of proteasomes, transporter for antigen presentation (TAP), and b 2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway
20. TAP peptide transporter-independent presentation of heat-killed sendai virus antigen on MHC class I molecules by splenic antigen-presenting cells
21. Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes
22. Exogenous antigens gain access to the major histocompatibility complex class I processing pathway in B cells by receptor-mediated uptake
23. Use of recombinant nucleoproteins in enzyme-linked immunosorbent assays for detection of virus-specific immunoglobulin A (IgA) and IgG antibodies in influenza virus A- or B-infected patients
24. Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes
25. Assembly and function of the two ABC transporter proteins encoded in the human histocompatibility complex
26. Presentation of exogenous antigen with class I major histocompatibility complex molecules
27. Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition
28. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages
29. Major histocompatibility complex class I presentation of exogenous soluble tumor antigen fused to the B-fragment of shiga toxin
30. MHC class I-restricted presentation of maleylated protein binding to scavenger receptors
31. + cytotoxic T lymphocytes
32. Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules
33. HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading
34. A subset of HLA-B27 molecules contains peptides much longer than nonamers
35. Cutting edge: HLA-B27 can form a novel β2-microglobulin-free heavy chain homodimer structure
36. Extracellular processing and presentation of a 69-mer synthetic polypeptide to MHC class I-restricted T cells
37. Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments
38. Recycling MHC class I molecules and endosomal peptide loading
39. Trafficking of spontaneously endocytosed MHC proteins
40. Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis
41. HLA-A2.1-associated peptides from a mutant cell line: A second pathway of antigen presentation
42. HLA-A2 molecules in an antigen-presenting mutant cell contain signal sequence-derived peptides
43. TAP (transporter associated with antigen processing)-independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences located at the amino- but not carboxyl-terminus of the peptide
44. T cell recognition of an HLA-A2-restricted epitope derived from a cleaved signal sequence
45. Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum
46. Two novel routes of transporter associated with antigen processing (TAP)-independent major histocompatibility complex class I antigen processing
47. TAP-independent delivery of antigenic peptides to the endoplasmic reticulum: Therapeutic potential and insights into TAP-dependent antigen processing
48. Major histocompatibility complex class I presentation of ovalbumin peptide 257-264 from exogenous sources: Protein context influences the degree of TAP-independent presentation
49. Characterization of transport of newly assembled, T cell-stimulatory MHC class II-peptide complexes from MHC class II compartments to the cell surface